Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
glimepiride/vildagliptin/metformin
(G/V/M) /
Laboratorios Silanes
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
||||
||||||
glimepiride/vildagliptin/metformin
(G/V/M) /
Laboratorios Silanes
Enrollment open, Trial completion date, Trial primary completion date:
Oral Combination of Glimepiride/Vildagliptin/Metformin in Patients With T2D and Dual Treatment Failure
(clinicaltrials.gov) - Oct 30, 2023
P3
, N=172, Recruiting,
Sponsor: Laboratorios Silanes S.A. de C.V.
Not yet recruiting --> Recruiting | Trial completion date: Mar 2022 --> Apr 2024 | Trial primary completion date: Aug 2021 --> Mar 2024
||||||||
||
glimepiride/vildagliptin/metformin
(G/V/M) /
Laboratorios Silanes
New P3 trial:
Oral Combination of Glimepiride/Vildagliptin/Metformin in Patients With T2D and Dual Treatment Failure
(clinicaltrials.gov) - Apr 12, 2021
P3
, N=172, Not yet recruiting,
Sponsor: Laboratorios Silanes S.A. de C.V.